Psychiatry Research: Neuroimaging
Volume 164, Issue 3 , Pages 274-282 , 30 December 2008

Impact of fluoxetine on the human brain in multiple sclerosis as quantified by proton magnetic resonance spectroscopy and diffusion tensor imaging

  • Paul E. Sijens

      Affiliations

    • Department of Radiology, University Hospital Groningen, and University of Groningen, The Netherlands
    • Corresponding Author InformationCorresponding author. Department of Radiology, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands. Tel.: +31 50 361 3534; fax: +31 50 361 1798.
    • ,
  • Jop P. Mostert

      Affiliations

    • Department of Neurology, University Hospital Groningen, and University of Groningen, The Netherlands
    • ,
  • Roy Irwan

      Affiliations

    • Department of Radiology, University Hospital Groningen, and University of Groningen, The Netherlands
    • Toshiba Medical Systems Europe, Zoetermeer, The Netherlands
    • ,
  • Jan Hendrik Potze

      Affiliations

    • Department of Radiology, University Hospital Groningen, and University of Groningen, The Netherlands
    • ,
  • Matthijs Oudkerk

      Affiliations

    • Department of Radiology, University Hospital Groningen, and University of Groningen, The Netherlands
    • ,
  • Jacques De Keyser

      Affiliations

    • Department of Neurology, University Hospital Groningen, and University of Groningen, The Netherlands

Received 19 April 2007 ,Revised 20 September 2007 ,Accepted 22 December 2007.

References 

  1. Alberts M, Smets EM, Vercoulen JH, Garssen B, Bleijenberg G. Abbreviated fatique questionnaire’: a practical tool in the classification of fatique. Nederlands Tijdschrift voor Geneeskunde. 1997;1526–1530
  2. Bammer R, Augustin M, Strasser-Fuchs S, Seifert T, Kapeller P, Stollberger R, et al. Magnetic resonance diffusion tensor imaging for characterizing diffuse and focal white matter abnormalities in multiple sclerosis. Magnetic Resonance in Medicine. 2000;44:583–591
  3. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Archives of General Psychiatry. 1961;4:561–571
  4. Brooks JCW, Roberts N, Kemp GJ, Gosney MA, Lye M, Whitehouse GH. A proton magnetic resonance spectroscopy study of age-related changes in frontal lobe metabolite concentrations. Cerebral Cortex. 2001;11:598–605
  5. Brown AM, Tekkok SB, Ransom BR. Glycogen regulation and functional role in mouse white matter. Journal of Physiology. 2003;549:501–512
  6. Charil A, Filippi M. Inflammatory demyelination and neurodegeneration in early multiple sclerosis. Journal of the Neurological Sciences. 2007;259:7–15
  7. Ciccarelli O, Werring DJ, Barker GJ, Griffin CM, Wheeler-Kingshott CA, Miller DH, et al. A study of the mechanisms of normal-appearing white matter damage in multiple sclerosis using diffusion tensor imaging-evidence of Wallerian degeneration. Journal of Neurology. 2003;250:287–292
  8. Chard DT, Griffin CM, McLean MA, Kapeller M, Kapoor R, Thomson AJ, et al. Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. Brain. 2002;125:2342–2352
  9. De Keyser J, Zeinstra J, Mostert J, Wilczak N. Beta 2-adrenoceptor involvement in inflammatory demyelination in multiple sclerosis. Trends in Pharmacological Sciences. 2004;25:67–71
  10. De Stefano N, Iannucci G, Sormani MP, Guidi L, Bartelozzi ML, Comi G, et al. MR correlates of cerebral atrophy in patients with multiple sclerosis. Journal of Neurology. 2002;249:1072–1077
  11. Filippi M, Cercignani M, Inglese M, Horsfield MA, Comi G. Diffusion tensor magnetic resonance imaging in multiple sclerosis. Neurology. 2001;56:304–311
  12. Irwan R, Sijens PE, Potze JH, Oudkerk M. Correlation of proton MR spectroscopy and diffusion tensor imaging. Magnetic Resonance Imaging. 2005;23:851–858
  13. Kaufman MJ, Henry ME, Frederick B, Hennen J, Villafuerte RA, Stoddard EP, et al. Selective serotonin reuptake inhibitor discontinuation syndrome is associated with a rostral anterior cingulate choline metabolite decrease: a proton magnetic resonance spectroscopic imaging study. Biological Psychiatry. 2003;54:34–539
  14. Kong EK, Peng L, Chen Y, Yu AC, Herz L. Up-regulation of 5-HT2B receptor by long-term fluoxetine administration. Neurochemistry Research. 2002;27:113–120
  15. Laule C, Vavasour IM, Moore GRW, Oger J, Li DKB, Paty DW, et al. Water content and myelin water fraction in multiple sclerosis; a T1 relaxation study. Journal of Neurology. 2004;251:284–293
  16. McDonald WI, Compston A, Edan G, Goodkin D, Hartung H-P, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Annals of Neurology. 2001;50:121–127
  17. Mostert JP, Sijens PE, Oudkerk M, De Keyser J. Fluoxetine increases cerebral white matter NAA/Cr ratio in patient with multiple sclerosis. Neuroscience Letters. 2006;402:22–24
  18. Oh J, Henry RG, Genain C, Nelson SJ, Pelletier D. Mechanisms of normal appearing injury related to pericallosal T1 lesions in multiple sclerosis using directional diffusion tensor and H-1 MRS imaging. Journal of Neurology, Neurosurgery, and Psychiatry. 2004;75:1281–1286
  19. Renshaw PF, Lafer B, Babb SM, Fava M, Stoll AL, Christensen JD, et al. Basal ganglia choline levels in the depression and response to treatment: an in vivo proton magnetic resonance study. Biological Psychiatry. 1997;41:837–843
  20. Roser W, Hagberg G, Mader I, Brunnschweiler H, Radue EW, Seelig J, et al. Proton MRS of gadolinium-enhancing MS plaques and metabolic changes in normal-appearing white matter. Magnetic Resonance in Medicine. 1995;33:811–817
  21. Sappey-Marinier D. High-resolution NMR spectroscopy of cerebral white matter in multiple sclerosis. Magnetic Resonance in Medicine. 1990;15:229–239
  22. Sastre-Garriga JS, Ingle GT, Chard DT, Ramio-Torrenta L, McLean MA, Miller DH, et al. Metabolic changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis. Archives of Neurology. 2005;62:569–573
  23. Sijens PE, van den Bent MJ, Nowak PJCM, van Dijk P, Oudkerk M. Chemical shift imaging reveals loss of brain tumor choline signal after administration of Gd-contrast agent. Magnetic Resonance in Medicine. 1997;37:222–2251997
  24. Sijens PE, den Heijer T, Origgi D, Vermeer SE, Breteler MMB, Hofman A, et al. Brain MR spectroscopy at a supraventricular plane showing changes with aging that differ between women and men. Radiology. 2003;226:889–896
  25. Sijens PE, Mostert JP, Oudkerk M, De Keyser J. 1H MR spectroscopy of the brain in multiple sclerosis subtypes with analysis of the metabolite concentrations in gray and white matter: initial findings. European Radiology. 2005;16:489–495
  26. Sijens PE, Irwan R, Potze JH, Mostert JP, De Keyser J, Oudkerk M. Analysis of the human brain in primary progressive multiple sclerosis with mapping of the spatial distributions using 1H MR spectroscopy and diffusion tensor imaging. European Radiology. 2005;15:1686–1693
  27. Sijens PE, Irwan R, Potze JH, Mostert JP, De Keyser J, Oudkerk M. Relationships between brain water content and diffusion tensor imaging parameters (apparent diffusion coefficient and fractional anisotropy) in multiple sclerosis. European Radiology. 2006;16:898–904
  28. Smith PF, Darlington CL. Recent developments in drug therapy for multiple sclerosis. Multiple Sclerosis. 1999;5:110–120
  29. Sonawalla SB, Renshaw PF, Moore CM, Alpert JE, Nierenberg AA, Rosenbaum JF, et al. Compounds containing cytosolic choline in the basal ganglia: a potential marker of true drug response to fluoxetine. American Journal of Psychiatry. 1999;156:1638–1640
  30. Srinivasan R, Sailasuta N, Hurd R, Nelson S, Pelletier D. Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. Brain. 2005;128:1016–1025
  31. Stys PK. General mechanisms of axonal damage and its prevention. Journal of the Neurological Sciences. 2005;233:3–13
  32. Tartaglia MC, Narayanan S, De Stefano N, Arnaoutelis R, Antel SB, Francis SJ, et al. Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis. Journal of Neurology. 2003;249:1382–1390
  33. Tourtellotte W, Parker J. Some spaces and barriers in postmortem multiple sclerosis. Progress in Brain Research. 1968;29:493–525
  34. Vrenken H, Pouwels PJW, Geurts JJG, Knol DL, Polman CH, Barkhof F, et al. Altered diffusion tensor in multiple sclerosis normal-appearing brain tissue: cortical diffusion changes seem related to clinical deterioration. Journal of Magnetic Resonance Imaging. 2006;23:628–636
  35. Werring DJ, Clarc CA, Berker GJ, Thomson AJ, Miller DH. Diffusion tensor imaging of lesions and normal appearing white matter in multiple sclerosis. Neurology. 1999;52:1626–1632

PII: S0925-4927(07)00261-2

doi: 10.1016/j.pscychresns.2007.12.014

Psychiatry Research: Neuroimaging
Volume 164, Issue 3 , Pages 274-282 , 30 December 2008

Article Tools

* Image Usage & Resolution